Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session Transcript
Welcome to the Roche presentation at the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to introduce from Roche, Bill Anderson, the CEO of Roche Pharmaceuticals.
Before I hand over to Bill, I'd just point out that the breakout session after his presentation is in the Borgia Room, which is at the back of the hall. Bill, welcome.
Thanks, Richard. Welcome, everyone. Thanks for being here. I have the duty now to tell you everything that's going on in Roche in 25 minutes. I won't try that.
I do want to -- I want to focus really on 3 themes, really, one is the strategy, which I think everyone is interested in and how we pull this all together, the many diverse parts of what Roche brings in pharmaceuticals, in diagnostics and in the insights businesses. But also I'm going to talk a little bit about culture and the cultural
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
